CVS Health Corp [CVS] stock prices are up 0.63% to $78.06 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The CVS shares have gain 3.79% over the last week, with a monthly amount glided 1.25%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 13, March 2024, AM Best Affirms Credit Ratings of Most of CVS Health Corporation’s Aetna Inc. Subsidiaries; Withdraws Credit Ratings of Members of Texas Health Aetna. In a post published today on Yahoo Finance, AM Best has affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICRs) of “a” (Excellent) of Aetna Life Insurance Company (ALIC) (Hartford, CT) and the other members of Aetna Health & Life Group, which are operating entities of Aetna Inc. (Aetna) and wholly owned subsidiaries of CVS Health Corporation (CVS Health) [NYSE: CVS]. The outlook of the FSR is stable, while the outlook of the Long-Term ICR is positive. (Please see below for a detailed listing of the companies.).
From an analyst’s perspective:
CVS Health Corp [NYSE: CVS] stock has seen the most recent analyst activity on March 06, 2024, when Barclays initiated its Equal Weight rating and assigned the stock a price target of $78. Previously, Leerink Partners started tracking the stock with Outperform rating on February 26, 2024, and set its price target to $88. On December 22, 2023, HSBC Securities initiated with a Buy rating and assigned a price target of $94 on the stock. Evercore ISI upgraded its rating to a Outperform and increased its price target to $83 on September 19, 2023. Wolfe Research upgraded its rating to a Outperform but $80 remained the price target by the analyst firm on September 12, 2023. Edward Jones downgraded its rating to Hold for this stock on August 18, 2023. In a note dated May 26, 2023, Piper Sandler initiated an Overweight rating and provided a target price of $85 on this stock.
The stock price of CVS Health Corp [CVS] has been fluctuating between $64.41 and $83.25 over the past year. Currently, Wall Street analysts expect the stock to reach $112.63 within the next 12 months. CVS Health Corp [NYSE: CVS] shares were valued at $78.06 at the most recent close of the market. An investor can expect a potential return of 44.29% based on the average CVS price forecast.
Analyzing the CVS fundamentals
The CVS Health Corp [NYSE:CVS] reported sales of 358.27B for trailing twelve months, representing a surge of 12.02%. Gross Profit Margin for this corporation currently stands at -0.03% with Operating Profit Margin at 0.04%, Pretax Profit Margin comes in at 0.03%, and Net Profit Margin reading is 0.02%. To continue investigating profitability, this company’s Return on Assets is posted at 0.03, Equity is 0.11 and Total Capital is 0.08. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 1.04.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 77.53 points at the first support level, and at 77.01 for the second support level. However, for the 1st resistance point, the stock is sitting at 78.74, and for the 2nd resistance point, it is at 79.43.
CVS Health Corp [CVS] reported earnings per share of $2.12 for its fiscal quarter that ended on 12/30/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of $1.99/share, meaning a difference of $0.13 and a surprise factor of 6.50%. By comparison, the stated earnings for the previous quarter ended on 9/29/2023 were $2.21 per share as compared to estimates of $2.13 per share, a difference of $0.08 representing a surprise of 3.80%.
Ratios To Look Out For
It’s worth pointing out that CVS Health Corp [NYSE:CVS]’s Current Ratio is 0.86. In addition, the Quick Ratio stands at 0.63 and the Cash Ratio stands at 0.1. Considering the valuation of this stock, the price to sales ratio is 0.27, the price to book ratio is 1.31 and price to earnings (TTM) ratio is 12.07.
Transactions by insiders
Recent insider trading involved Shah Prem S, EVP and Pres-Pharm, Consumer W, that happened on Feb 16 ’24 when 29473.0 shares were sold. Director, LUDWIG EDWARD J completed a deal on Nov 03 ’23 to buy 2000.0 shares. Meanwhile, SVP, Cont & Chief Acct Officer Clark James David sold 25759.0 shares on Aug 03 ’23.
